Sutter Health Medical Devices Send Data Directly to Epic MyChart
The ‘Sutter Sync’ devices will support patients managing Type 2 diabetes, high blood pressure and those who are pregnant
The ‘Sutter Sync’ devices will support patients managing Type 2 diabetes, high blood pressure and those who are pregnant
Carolyn Dickens, 76, was sitting at her dining room table, struggling to catch her breath as her physician looked on with concern. “What’s going on with your breathing?” asked Peter Gliatto, director of Mount Sinai’s Visiting Doctors Program. “I don’t know,” she answered, so softly it was hard to hear. “Going from here to the…
The phenomenon of taking five or more medicines at the same time has become so common that it now has its own term – polypharmacy – and there is no doubt that it increases the risk of dizziness, confusion, and loss of balance. The post Too Many Prescriptions, Too Many Fatal Falls appeared first on…
Employers are projecting a median 10% increase in healthcare costs for 2026, driven largely by high claims and specialty drug expenses, according to a recent survey. The post Why Employers Predict a 10% Increase in Healthcare Costs for 2026 appeared first on MedCity News.
Grow Therapy’s Series D funding was led by TCV and Growth Equity at Goldman Sachs Alternatives, with participation from BCI, Menlo Ventures, Sequoia, SignalFire and Transformation Capital. The post Grow Therapy Raises $150M to Expand Employer, Health System Partnerships appeared first on MedCity News.
Idaho-based health system St. Luke’s is rolling out Ambience Healthcare’s AI platform across its enterprise following a successful pilot. The AI-powered scribing tool decreased clinicians’ documentation time by 39%. The post How Ambience Is Saving Clinicians from ‘the Perpetual Dread’ of Documentation Overload appeared first on MedCity News.
Structure Therapeutics’ aleniglipron, a once-daily oral GLP-1 drug, led to an average 16% weight loss measured at 44 weeks. Based on these results, the biotech is preparing for Phase 3 testing expected to begin in the second half of this year. The post Structure Therapeutics Oral GLP-1 Obesity Drug Achieves ‘Injectable-Like Efficacy’ in Phase 2…
Regeneron Pharmaceuticals’ $256 million offer was chosen the winner of 23andMe’s bankruptcy auction. Drug research never became a big part of the genetic testing company’s business, but it is getting a new life by joining Regeneron Genetics Center, a Regeneron subsidiary that analyzes genetic data for drug R&D. The post 23andMe Bankruptcy Auction Win Adds…
Carrum Health has expanded its value-based substance use program to include cannabis, sedatives and stimulants. The post Carrum Health Expands SUD Treatment Program to Include Nearly All Substances appeared first on MedCity News.
TUSCALOOSA, Ala. — Like most medical offices, the small suite of exam rooms at the PhiferCares Clinic fills daily with patients seeking help with bumps and bruises, sore throats, and stuffy noses. But there’s an important difference about this clinic in central Alabama: No one gets a bill, including for prescriptions. That’s because the clinic…